Teva Stock Highest Level: Why It Could Soar Further
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
Evaluating traditional loans versus credit builder options helps you determine the best path for credit growth based on your situation.
25,423 articlesTeva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Rising demand for care and a wave of retirements are shaping a looming doctor shortage. AI technologies may slash adm...
Former White House adviser Kevin Hassett publicly endorses Fed Chair nominee Kevin Warsh's policy plan, signaling a s...
As Zoom prepares for 2026, investors want to know how the company will grow revenue, expand margins, and win with AI....
Two major price cuts from Chinese AI labs are changing the economics of frontier AI. For crypto traders and funds, ch...
Kingsoft Cloud KC 2026 Q1 sets the tone for the year. This guide breaks down what to watch in margins, segments, and ...
Could Palantir move higher over the next year? This guide breaks down three realistic scenarios, key catalysts, and p...
A reality-TV star running for Los Angeles mayor isn’t just drama—it’s a real test of how city budgets, taxes, and pub...
Lululemon faces a pivotal moment after its latest earnings. This analysis breaks down what's working, what's slowing,...
Friday's 14% plunge in ProShares UltraPro QQQ wiped out most of the gains from a high-octane tech rally, illustrating...
Small-cap biotech Aethlon Medical faces a pivotal year in 2026. This guide breaks down what to watch in aethlon (aemd...